Contract manufacturing firms are ramping up the adoption of Pharma 4.0 technologies as regulators and customers increasingly look for transparency and integrity in manufacturing data. Pharma 4.0 enables a new level of transparency in manufacturing that has never been seen before. It allows access to the same data for every player along the supply chain.
Real-time access to manufacturing data is something every client would love to have.

While North America and Europe are at the forefront, the digital shift is happening globally. However, challenges remain, including high implementation costs, workforce resistance, cybersecurity risks, etc. Experts stress the importance of changing workforce mentality to digitization, reskilling employees, integrating robust cybersecurity measures, and aligning automation and digitization investments to a risk management framework. The latter would help customers adapt and evolve their security strategy based on the threats they face and how they want to respond.

This article explores the tools and technologies CDMOs are adopting to transform their production facilities into smart factories of the future.

To learn about digitization initiatives across the drug discovery, development and manufacturing continuum at Syngene, contact our experts.